Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic CancerThomas B. Karasic, Peter J. O’Dwyer, Mark H. O’Hara et al.|JAMA Oncology|2019Cited by 289
Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in <i>BRCA1</i>, <i>BRCA2</i>, or <i>PALB2</i>Kim A. Reiss, Susan M. Domchek, Rosemarie Mick et al.|Journal of Clinical Oncology|2021Cited by 238
Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trialKim A. Reiss, Robert H. Vonderheide, Ursina Teitelbaum et al.|The Lancet Oncology|2022Cited by 137
Phase 2 trial of bevacizumab, capecitabine, and oxaliplatin in treatment of advanced hepatocellular carcinomaWeijing Sun, Kim M. Olthoff, Davendra Sohal et al.|Cancer|2011Cited by 97
A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinomaDavendra Sohal, Weijing Sun, Ursina Teitelbaum et al.|Annals of Oncology|2013Cited by 89